journal article·2023-04-26Open access

Thermoplasmonic Vesicle Fusion Reveals Membrane Phase Segregation of Influenza Spike Proteins

Guillermo Moreno-Pescador, Mohammad Reza Arastoo, Victoria Thusgaard Ruhoff, Salvatore Chiantia, Robert Daniels, Poul Martin Bendix

Nano Letters· Volume 23· Issue 8

Abstract

Many cellular processes involve the lateral organization of integral and peripheral membrane proteins into nanoscale domains. Despite the biological significance, the mechanisms that facilitate membrane protein clustering into nanoscale lipid domains remain enigmatic. In cells, the analysis of membrane protein phase affinity is complicated by the size and temporal nature of ordered and disordered lipid domains. To overcome these limitations, we developed a method for delivering membrane proteins from transfected cells into phase-separated model membranes that combines optical trapping with thermoplasmonic-mediated membrane fusion and confocal imaging. Using this approach, we observed clear phase partitioning into the liquid disordered phase following the transfer of GFP-tagged influenza hemagglutinin and neuraminidase from transfected cell membranes to giant unilamellar vesicles. The generic platform presented here allows investigation of the phase affinity of any plasma membrane protein which can be labeled or tagged with a fluorescent marker.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Lipid Membrane Structure and Behavior · Immune Response and Inflammation · RNA and protein synthesis mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Niels Bohr Institute, University of Copenhagen, Blegdamsvej 17, 2100 København Ø, Denmark

Institute of Biochemistry and Biology, University of Potsdam, Karl-Liebknecht-Str. 24-25, 14476 Potsdam, Germany

Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993, United States

Funding

Det Frie Forskningsr??d · Novo Nordisk Fonden · German Research Foundation

References (64)

Show source-provided references
1. 10.1194/jlr.M00154510.1194/jlr.M001545 ↗
2. 10.1016/j.tcb.2020.01.00910.1016/j.tcb.2020.01.009 ↗
3. 10.1016/S0955-0674(00)00238-610.1016/S0955-0674(00)00238-6 ↗
4. 10.4049/jimmunol.168.8.409510.4049/jimmunol.168.8.4095 ↗
5. 10.1182/blood-2006-04-01682410.1182/blood-2006-04-016824 ↗
6. 10.1155/2012/76328310.1155/2012/763283 ↗
7. 10.1194/jlr.TR11900043910.1194/jlr.TR119000439 ↗
8. 10.1371/journal.pone.007689310.1371/journal.pone.0076893 ↗
9. 10.1111/cmi.1210110.1111/cmi.12101 ↗
10. 10.1016/bs.ctm.2015.03.00510.1016/bs.ctm.2015.03.005 ↗
11. 10.1073/pnas.08107529810.1073/pnas.081075298 ↗
12. 10.1111/j.1600-065X.1999.tb01279.x10.1111/j.1600-065X.1999.tb01279.x ↗
13. 10.1073/pnas.120940810910.1073/pnas.1209408109 ↗
14. 10.1128/JVI.78.10.5258-5269.200410.1128/JVI.78.10.5258-5269.2004 ↗
15. 10.1155/2011/37060610.1155/2011/370606 ↗
16. 10.1016/j.bbamem.2015.12.02110.1016/j.bbamem.2015.12.021 ↗
17. 10.1042/BST2021088310.1042/BST20210883 ↗
18. 10.1038/4240810.1038/42408 ↗
19. 10.1038/s41556-019-0300-y10.1038/s41556-019-0300-y ↗
20. 10.1002/pro.556007042010.1002/pro.5560070420 ↗
21. Alberts B. · 2014
22. 10.1371/journal.pcbi.100243110.1371/journal.pcbi.1002431 ↗
23. 10.1146/annurev.bi.57.070188.00144110.1146/annurev.bi.57.070188.001441 ↗
24. 10.1016/0092-8674(92)90189-J10.1016/0092-8674(92)90189-J ↗
25. 10.1038/nchembio.102810.1038/nchembio.1028 ↗
26. 10.1126/science.771651210.1126/science.7716512 ↗
27. 10.1074/jbc.M40648220010.1074/jbc.M406482200 ↗
28. 10.1016/j.imlet.2003.10.01310.1016/j.imlet.2003.10.013 ↗
29. 10.1073/pnas.140458211110.1073/pnas.1404582111 ↗
30. 10.1126/science.117462110.1126/science.1174621 ↗
31. 10.1038/nrm.2017.1610.1038/nrm.2017.16 ↗
32. 10.1002/jss.40001030710.1002/jss.400010307 ↗
33. 10.3109/09687688.2012.70049010.3109/09687688.2012.700490 ↗
34. 10.1016/j.bpj.2010.04.02710.1016/j.bpj.2010.04.027 ↗
35. Garten M. · J. Visualized Exp. · 2015 · 1
36. 10.1016/j.virol.2005.09.04910.1016/j.virol.2005.09.049 ↗
37. 10.1021/acsnano.9b0105210.1021/acsnano.9b01052 ↗
38. 10.1021/acs.nanolett.5b0136610.1021/acs.nanolett.5b01366 ↗
39. 10.1088/1361-6633/aa996610.1088/1361-6633/aa9966 ↗
40. 10.1021/acs.chemrev.8b0073810.1021/acs.chemrev.8b00738 ↗
41. 10.1039/C8NR02275E10.1039/C8NR02275E ↗
42. 10.1083/jcb.20041205810.1083/jcb.200412058 ↗
43. 10.1016/j.bpj.2013.03.05410.1016/j.bpj.2013.03.054 ↗
44. 10.1016/j.bpj.2015.02.02610.1016/j.bpj.2015.02.026 ↗
45. 10.1016/j.virol.2010.12.00310.1016/j.virol.2010.12.003 ↗
46. 10.1073/pnas.223562010010.1073/pnas.2235620100 ↗
47. 10.1073/pnas.101618410710.1073/pnas.1016184107 ↗
48. 10.1038/s41598-018-28858-010.1038/s41598-018-28858-0 ↗
49. 10.1083/jcb.20170210210.1083/jcb.201702102 ↗
50. 10.1074/jbc.M40702020010.1074/jbc.M407020200 ↗
51. 10.1073/pnas.101618410710.1073/pnas.1016184107 ↗
52. 10.1093/emboj/16.18.550110.1093/emboj/16.18.5501 ↗
53. 10.1042/BJ2006005610.1042/BJ20060056 ↗
54. 10.1016/S0022-2836(03)00504-710.1016/S0022-2836(03)00504-7 ↗
55. 10.1038/s41589-020-0529-610.1038/s41589-020-0529-6 ↗
56. 10.1242/jcs.35.1.22910.1242/jcs.35.1.229 ↗
57. 10.1016/j.bpj.2021.11.02310.1016/j.bpj.2021.11.023 ↗
58. 10.1128/JVI.00361-0710.1128/JVI.00361-07 ↗
59. 10.1073/pnas.090898710610.1073/pnas.0908987106 ↗
60. 10.1038/nprot.2012.05910.1038/nprot.2012.059 ↗
61. 10.1021/nn901751w10.1021/nn901751w ↗
62. 10.1021/acs.nanolett.5b0136610.1021/acs.nanolett.5b01366 ↗
63. 10.5281/zenodo.757742710.5281/zenodo.7577427 ↗
64. 10.1002/dvg.2020310.1002/dvg.20203 ↗